Rescue from programmed cell death in leukemic and normal myeloid cells.

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Myeloid leukemic cells can lose growth factor independence during differentiation.
• This differentiation can lead to programmed cell death (apoptosis) in the absence of growth factors.
• Understanding the mechanisms regulating apoptosis in these cells is crucial for cancer therapy.

Purpose of the Study:

• To investigate the mechanisms of apoptosis in differentiating myeloid leukemic cells.
• To identify factors that can rescue these cells from apoptosis.
• To explore the role of tumor promoters in regulating programmed cell death.

Main Methods:

• Culturing myeloid leukemic cell clones and normal myeloid precursor cells.
• Inducing differentiation and observing viability in the absence of growth factors.
• Assessing apoptosis using DNA fragmentation and morphologic changes.
• Testing the rescue effects of interleukin-3 (IL-3), 12-O-tetra-decanoyl-phorbol-13-acetate (TPA), and 4-alpha-TPA.
• Investigating the role of the Na+/H+ antiporter using amiloride inhibitors.

Main Results:

• Differentiating leukemic cells exhibited apoptosis without growth factors, characterized by DNA fragmentation.
• Interleukin-3 (IL-3) and the tumor promoter 12-O-tetra-decanoyl-phorbol-13-acetate (TPA) rescued these cells from apoptosis.
• The nonpromoting phorbol ester 4-alpha-TPA did not prevent apoptosis.
• IL-3 and TPA acted through different pathways to rescue cells.
• Both IL-3 and TPA also rescued normal myeloid precursor cells from apoptosis.
• Amiloride inhibitors of the Na+/H+ antiporter blocked the rescue effects of IL-3 and TPA.

Conclusions:

• Programmed cell death (apoptosis) is a significant event in differentiating myeloid leukemic cells lacking growth factors.
• Hematopoietic growth factors like IL-3 and tumor promoters like TPA can inhibit apoptosis in both leukemic and normal myeloid cells.
• TPA may function as a tumor promoter by suppressing programmed cell death.
• The Na+/H+ antiporter appears to be involved in the anti-apoptotic signaling pathways activated by IL-3 and TPA.